Genomic Alterations Identification and Resistance Mechanisms Exploration of NSCLC With Central Nervous System Metastases Using Liquid Biopsy of Cerebrospinal Fluid: A Real-World Study.
Frontiers In Oncology
Shen, Fangfang F; Liang, Naixin N; Fan, Zaiwen Z; Zhao, Min M; Kang, Jing J; Wang, Xifang X; Hu, Qun Q; Mu, Yongping Y; Wang, Kai K; Yuan, Mingming M; Chen, Rongrong R; Guo, Wei W; Dong, Guilan G; Zhao, Jun J; Bai, Jun J
Publication Date: 2022
Variant appearance in text: CYP2D6: 1009G>A; D337N
Comparative analysis of primary versus relapse/refractory DLBCL identifies shifts in mutation spectrum.
Oncotarget
Greenawalt, Danielle M DM; Liang, Winnie S WS; Saif, Sakina S; Johnson, Justin J; Todorov, Petar P; Dulak, Austin A; Enriquez, Daniel D; Halperin, Rebecca R; Ahmed, Ambar A; Saveliev, Vladislav V; Carpten, John J; Craig, David D; Barrett, J Carl JC; Dougherty, Brian B; Zinda, Michael M; Fawell, Stephen S; Dry, Jonathan R JR; Byth, Kate K
Publication Date: 2017-11-21
Variant appearance in text: CYP2D6: 1009G>A; D337N; rs78209835
Flexible and Scalable Full-Length CYP2D6 Long Amplicon PacBio Sequencing.
Human Mutation
Buermans, Henk P J HP; Vossen, Rolf H A M RH; Anvar, Seyed Yahya SY; Allard, William G WG; Guchelaar, Henk-Jan HJ; White, Stefan J SJ; den Dunnen, Johan T JT; Swen, Jesse J JJ; van der Straaten, Tahar T
Publication Date: 2017-03
Variant appearance in text: CYP2D6: Asp337Asn; rs78209835